InsidersTradesSigma
Explore the full record of transactions filed by Ulf Hannelius, Chairman & CEO. Director active across 2 companies, notably Diamyd Medical AB. Cumulatively, 1 filings have been logged. Activity tracked since 5 May 2025. The latest transaction was disclosed on 5 May 2025 (Purchase). Regulator: FIN-FSA. All data is openly available.
1 of 1 declaration
Ulf Hannelius is the Chief Executive Officer of Diamyd Medical AB. He is responsible for the strategic direction of the company, overseeing its operations and ensuring performance objectives are met. Ulf plays a key role in developing innovative medical solutions.